# Risedronate Sodium

NDC: 65862-870
Generic name: Risedronate Sodium
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20161021

FDA application: ANDA206768

## Active ingredients

- RISEDRONATE SODIUM: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-870"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-870
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a42a35e6-3e08-4b4f-ae56-47d4aec2322a